Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06372249 · ClinicalTrials.gov registry record · Phase 2

A Clinical Trial of Soluble Fiber for Asthma

A Phase 2 study of Asthma in Children, sponsored by Phoenix Children's Hospital.

Recruiting
Registry status
Phase 2
Development phase
105
Enrollment target
1
Study location

NCT06372249 is a Phase 2 study of Asthma in Children that is actively recruiting participants, run by Phoenix Children's Hospital. The registered enrollment target is 105 participants, below the 203-participant average among 44 other Asthma in Children trials with a reported enrollment target (48% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06372249, a Phase 2 study of Asthma in Children, is actively recruiting participants, sponsored by Phoenix Children's Hospital.

RECRUITING
Registry status
Phase 2
Development phase
105 participants
Enrollment target
1
Study location

Study Summary

Randomized controlled trial of soluble fiber (Fruitafit Inulin). Participants will complete an ASA 24 dietary recall questionnaire to access their fiber intake. If eligible for the study, participants will be supplemented to their target fiber dosage with either soluble fiber (Fruitafit Inulin) or placebo. Collection of blood serum, fecal samples, and nasal wash will aid in analyzing the microbes present in one's gut and how fiber and diet may impact it. Thus, allowing researchers to better understand the pathways that may connect diet and asthma and if it is possible to improve asthma by altering one's diet.

Conditions Studied

Interventions

  • DRUG Inulin

Study Locations (1)

Arizona

  • Phoenix Children's - Phoenix

Trial Details

FieldValue
Enrollment Target 105 participants
Start Date 2025-11-10
Est. Completion 2027-05-31
Phase Phase 2

Sponsor

Phoenix Children's Hospital

26 total trials

What the Registry Record Tells You About NCT06372249

The ClinicalTrials.gov registry entry for NCT06372249 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 203-participant average among 44 other Asthma in Children trials with a reported enrollment target (48% lower). The listed sponsor is Phoenix Children's Hospital, which has 26 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Asthma in Children appearing as the primary indexed condition, and to 1 intervention - of which Inulin is the first listed.

NCT06372249 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.

Frequently Asked Questions

What is clinical trial NCT06372249 about?

NCT06372249 is a clinical study titled "A Clinical Trial of Soluble Fiber for Asthma". Randomized controlled trial of soluble fiber (Fruitafit Inulin). Participants will complete an ASA 24 dietary recall questionnaire to access their fiber intake. If eligible for the study, participants will be supplemented to their target fiber dosage with either soluble fiber (Fruitafit Inulin) or p...

What is the current status of trial NCT06372249?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 105 participants. The study started on 2025-11-10. Estimated completion is 2027-05-31.

What conditions does trial NCT06372249 study?

This clinical trial studies the following conditions: Asthma in Children.

What interventions are being tested in trial NCT06372249?

The interventions under investigation include: Inulin (DRUG).

Who is sponsoring clinical trial NCT06372249?

This trial is sponsored by Phoenix Children's Hospital, which has 26 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06372249 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Asthma in Children

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.